
What regulators have authorised and why it matters Japan has given regulatory approval to two novel stem‑cell therapies aimed at treating Parkinson’s disease and severe heart failure, marking a first for such treatments nationally and a notable milestone glob…
Japan has given regulatory approval to two novel stemcell therapies aimed at treating Parkinsons disease and severe heart failure, marking a first for such treatments nationally and a notable milesto… [+1661 chars]









